Table 1.
Selected clinical characteristics and numbers seropositive for tularaemia among the study participants, northeastern Kenyaa
| Clinical symptoms and signs | Positive for tularaemia (N = 27) |
Negative for tularaemia (N = 703) |
p value |
|---|---|---|---|
| n (%) | n (%) | ||
| Lymphadenopathy | 16 (59.3) | 128 (18.2) | <0.001* |
| Arthralgia/myalgia | 15 (55.6) | 506 (72.0) | 0.202 |
| Malaise/fatigue | 14 (51.9) | 499 (70.9) | 0.033* |
| Painful lymph nodes | 8 (29.6) | 89 (12.8) | 0.018* |
| Headache | 8 (29.6) | 423 (60.1) | 0.080 |
| Weight loss | 7 (25.9) | 102 (14.5) | 0.317 |
| Acute lower respiratory illness | 5 (18.5) | 152 (21.6) | 0.460 |
| Cutaneous lesions | 5 (18.5) | 111 (15.8) | 0.698 |
| Sore throat | 9 (33.3) | 138 (19.6) | 0.109 |
| Vomiting | 2 (7.4) | 28 (3.9) | 0.920 |
| Abdominal pain | 4 (14.8) | 165 (23.5) | 0.064 |
| Diarrhoea | 3 (11.1) | 87 (12.3) | 0.294 |
| Rash | 1 (3.7) | 35 (4.8) | 0.571 |
| Hepato-splenomegaly | 3 (11.1) | 94 (12.9) | 0.610 |
| History of fever (>14 days) | 9 (33.3) | 262 (37.3) | 0.678 |
| Age, mean ± SD (years) | 33.2 ± 12.4 | 34.5 ± 12.1 | 0.595 |
| Fever onset/median (days) | 17.8/6 | 15.1/8 | 0.374 |
*Statistically significant, χ2 tests p < 0.05.
a
Patients with ELISA-positive results confirmed by Western blot.